CEO and Chair N Anthony Coles sold $1.3M of Cerevel Therapeutics Holdings, Inc.

Sold$1,333,300

$26.67Price

50,000Shares

−95%Stake

What CERE did after the filing

Prices for CERE after this filing aren't in yet.

Traded Fri, Dec 9. Filed Tue, Dec 13, 11:44 AM ET, during the session. Not investment advice.